版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
Chapter27
Antipyretic-AnalgesicandAntiinflammatoryDrugsA.GeneralPharmacologicalproperties1.Inhibitionofprostaglandinsynthesisinhibiting
cyclooxygenase(COX,環(huán)氧酶),decreasingthesynthesisofPGsandTXA2,resultingantipyretic,analgesic,andanti-inflammatoryeffectsnon-steroidalanti-inflammatorydrugs(NSAIDs,非甾體抗炎藥)。2.AntipyreticeffectsInhibitionofPGE2productioninthehypothalamusinducedbyendogenouspyregensafterpathologicalstimulitemperaturenotes:
symptomaticcontrolonly,notbeindicatedinallpatientswithfever.
Theeffectonbodytemperatureisdifferentfromthatofchlorpromazine.A.GeneralPharmacologicalpropertiesComparisonofpropertiesoftwotypesofdrugs3.AnalgesiceffectsAnalgesiceffectisresultedfrominhibitionofPGE2production.Effectiveonthepainoflowtomoderateintensityrelatedtoinflammatoryresponses.PGE2:apainstimulantandhyperalgesicagentTheanalgesiceffectisdifferentfromopioidanalgesics.A.GeneralPharmacologicalpropertiesComparisonofpropertiesoftwotypesofdrugs4.Anti-inflammatoryeffects
PGsinduceinflammatoryresponses.InhibitionofPGproductioncanrelieveinflammatoryresponses,suchascongestion,exudation,pain.Theeffectisdifferentfromthatofglucocorticosteroids.A.GeneralPharmacologicalpropertiesComparisonofpropertiesoftwotypesofdrugs5.COX-1/COX-2andselectivityofthedrugsCOX-1:
constructive;
involvedinphysiologicregulatoryfunctionsinGItract,kidney,etc.;
inhibitionofCOX-1isrelatedtotheadverseeffects.COX-2:
inducible;involvedinpathologicalresponsessuchasinflammation,andpregnancy;
inhibitionofCOX-2isrelatedtothetherapeuticeffects.
A.GeneralPharmacologicalproperties(-)(+)(+)(-)B.SalicylatesAspirin阿司匹林Acetylsalicylicacid乙酰水楊酸Aspirin阿司匹林Salicylicacid水楊酸Salicylicsodium水楊酸鈉Aspirin阿司匹林1.ADMEtransformedtosalicylicacidforminthebodyhepaticmetabolismisprimarilyconjugation.excretionfromurine,theexcretionofunchangedformsofaspirinisincreasedinthealkalinizedurine.largerdoses(>1g/d):
non-linearelimination,zeroorderkineticprocess,easiertoaccumulationandintoxication.B.Salicylates2.Pharmacologicaleffectsandclinicaluses(1)Antipyretic,analgesicandanti-inflammatoryeffects
moderatedoses(0.3~0.6g):antipyreticandanalgesiceffects
largerdoses(3~5g/d):anti-inflammatoryandanti-rheumaticeffects;onlyrelievessymptoms.
totreatacuterheumaticfever(急性風(fēng)濕熱),toabatepainandsymptomsofrheumatic&rheumatoidarthritis(風(fēng)濕性和類風(fēng)濕性關(guān)節(jié)炎).B.Salicylates(2)Inhibitionofplateletaggregation
smalldoses(30~100mg/d):inhibitingTXA2synthesis,preventingthrombosis.usedtotreatischemicheartdisease,reducethemortalityofmyocardiacinfarction,andpreventcerebralthrombosis.
largerdoses:inhibitingPGI2synthesis,promotingthrombosis.
PGI2:vasodilationandplateletdepolymerization(血小板解聚).
B.SalicylatesThemechanismofaspirin:Targetenzymesacetylated3.Adverseeffects(1)GIreactions
stimulatinggastricmucosaandCTZ(largerdoses);inhibitingPGsynthesisinGItractirritantsymptoms;gastricbleeding;ulcerousdisordersContraindications:ulcerousdisordersB.Salicylates(2)Prolongationofbleedingtimesmalldoses:inhibitingplateletaggregationlargerdoses:inhibitingsynthesisofthrombogen
Contraindications:oneweekpriortosurgery;severehepaticdamage;vitaminKdeficiency,;prothrombinopenia(凝血酶原減少癥).B.Salicylates(3)Allergicreactionsurticaria(蕁麻疹),angioneuroticedema,aspirin-inducedasthma,occasionallyanaphylacticshock.Contraindications:
bronchialasthmaB.SalicylatesAspirin-inducedasthma:
Phospholipidsofcellmenbrane
Aspirin
PhospholipaseA2(PLA2)(-)Arachidonicacid
CyclooxygenaseLipoxygenenase
(環(huán)氧酶)PGH25-HPETE(脂氧酶)
↓Prostaglandins(PGs)
↑Leukotrienes(LTs)
(前列腺素)
(白三烯)(4)Salicylism
dose>5g/d:CNSsymptoms,includingmentalconfusion;hyperventilation.i.v.NaHCO3canpromotetheexcretionofaspirin.
(5)Hepaticdamage
Overdose:hepaticdamage
Reye’ssyndrome(瑞夷綜合征):inchildren,severehepaticdamage(嚴(yán)重的肝損害)andencephalopathy(腦病)B.SalicylatesDose-responserelationshipofaspirin:therapeuticeffects;adverseeffects4.DruginteractionsB.SalicylatesC.Para-aminophenolderivativesAcetaminophen對(duì)乙酰氨基酚Paracetamol
撲熱息痛Acetaminophen(對(duì)乙酰氨基酚):
antipyreticandanalgesiceffectsaremildandlasting,butalmostnoanti-inflammatoryeffects,-nota
NSAIDhigherselectivitytoCOXinCNS.
mainlyusedincold,fever,andheadache,etc.
overdosecandamageliverandkidney.C.Para-aminophenolderivativesDifferencesbetweenNSAIDsandAcetaminophenToxicmetabolitesofacetaminophenD.Otheranti-inflammatorydrugsSalicylates:aspirinPara-aminophenolderivatives:acetaminophenIndoleandindeneaceticacidderivatives:indomethacin,sulindacPropionicacidderivatives:
ibuprofen,naproxen,fenopofen,ketoprofenCOX-2selectiveinhibitors:meloxicam,celecoxid
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 旅游景區(qū)商業(yè)設(shè)施設(shè)計(jì)方案
- 2025-2030中亞農(nóng)機(jī)設(shè)備制造行業(yè)供需分析及農(nóng)業(yè)現(xiàn)代化規(guī)劃評(píng)估發(fā)展市場(chǎng)研究報(bào)告
- 某發(fā)動(dòng)機(jī)廠檔案管理工作制度
- 文庫(kù)發(fā)布:免疫力科普
- (2026年)JAK抑制劑治療風(fēng)險(xiǎn)評(píng)估共識(shí)課件
- 非計(jì)劃性拔管預(yù)防及處理培訓(xùn)試題及答案
- 物業(yè)小區(qū)供水管道維修安全試題庫(kù)及答案
- 礦石處理工安全宣教知識(shí)考核試卷含答案
- 木質(zhì)家具制作工安全知識(shí)競(jìng)賽能力考核試卷含答案
- 2025至2030中國(guó)跨境電商獨(dú)立站流量獲取成本與變現(xiàn)效率分析報(bào)告
- T-CSTM 00394-2022 船用耐火型氣凝膠復(fù)合絕熱制品
- 滬教版6年級(jí)上冊(cè)數(shù)學(xué)提高必刷題(有難度) (解析)
- DBJ50-T-086-2016重慶市城市橋梁工程施工質(zhì)量驗(yàn)收規(guī)范
- 固態(tài)電池及固態(tài)電池的制造方法培訓(xùn)課件
- 川農(nóng)畢業(yè)論文開題報(bào)告
- UL1012標(biāo)準(zhǔn)中文版-2018非二類變壓器UL中文版標(biāo)準(zhǔn)
- sqe主管述職報(bào)告
- 出納常用表格大全
- 《頭暈與眩暈診斷》課件
- 2022年江蘇職教高考市場(chǎng)營(yíng)銷試卷
- 計(jì)量器具-GRR分析表格
評(píng)論
0/150
提交評(píng)論